Fox Business - The Power to Prosper
Search Site

Wednesday, April 7, 2010 as of 11:14 AM ET

Bayer AG

More Headlines »« Less Headlines

Bayer AG () is a chemical and pharmaceutical company founded in Barmen (today a part of Wuppertal), Germany in 1863. It is headquartered in Leverkusen, North Rhine-Westphalia, Germany and well known for its original brand of aspirin.

Read More at Wikipedia ›

Related Topics

  1. Marijn Dekkers
  2. Linde AG
  3. Daimler
  4. Quest Diagnostics
  5. Regeneron Pharmaceuticals
  6. Volkswagen
Get updates on Bayer AG
Bayer Backs Xarelto Sales Forecast After FDA Panel Votes Against Expanded Use

German pharmaceutical company Bayer AG (BAYN.

XE) Thursday confirmed it sees peak annual sales of its Xarelto drug above EUR2 billion after a U.S. Food and Drug Administration advisory panel voted against expanded use of the blood thinner.The FDA advisers narrowly voted against the use of the anti-clotting pill to treat patients with a heart problem known as acute coronary syndrome because of concerns about life-threatening bleeding.A spokesman for Bayer's HealthCare unit said the majority of sales are expected to come from the use of Xarelto in stroke prevention in patients with atrial fibrillation.The spokesman added the company will hold talks with the FDA and try to answer its questions.Warburg Research analyst Ulrich Huwald said the chances of a recommendation were low, so it wasn't surprising Bayer confirmed the Xarelto sales forecast.Xarelto is developed by Bayer and Johnson and Johnson (JNJ).Copyright © 2012 Dow Jones Newswires...

Read More ›

  1. Piramal Healthcare To Buy US Firm For About $635 Million

    Piramal Healthcare Ltd. (500302.BY) said Wednesday it will acquire U.S.-based health-information manager Decision Resources Group for about $635 million, the second ...

  2. OncoMed Pharmaceuticals Unveils Plans for $115 Million IPO

    OncoMed Pharmaceuticals Inc. unveiled plans for an initial public offering, hoping to raise up to $115 million for the development of investigational anti-cancer dru...

  3. Europe Stocks In Rebound Mode, Led By Resources

    European stock markets opened mostly higher on Thursday, attempting to rebound from sharp losses the prior day, with investors calming somewhat over Greece and Spain...

  4. Johnson & Johnson Seeks Further FDA Thrombosis OK For Xarelto

    Bayer AG (BAYN.XE) said Wednesday its cooperation partner, Johnson & Johnson's (JNJ) Janssen Research & Development LLC, has applied to the U.S. Food and Drug Admini...

  5. Bayer Seeking To Divest Diabetes Device Unit -Report

    Germany's Bayer AG (BAYN.XE) has contacted rivals to sound out their interest in buying its diabetes instrument business, German daily Financial Times Deutschland re...

  6. Bayer Could Get EUR1 Billion With Diabetes Device Unit Sale -Report

    Germany's Bayer AG (BAYN.XE) has contacted rivals to sound out their interest in buying its diabetes instrument business, German daily Financial Times Deutschland re...

  7. Bayer Appeals India Patent Office Ruling On Cancer-Drug License

    Germany's Bayer AG (BAYRY, BAYN.XE) has appealed against the grant of a compulsory license by India's patent authority to a local generic drug producer for its kidne...

  8. Johnson & Johnson Applies For Further FDA Approval Of Xarelto

    Bayer AG (BAYN.XE) said Wednesday cooperation partner Johnson & Johnson (JNJ) has asked the U.S. Food and Drug Administration for approval of using Xarelto to treat ...

  9. Europe Stocks Rally; Oil Firms, Drug Makers Rise

    European stock markets rallied on Wednesday, with drug makers and oil firms supporting the most. Most markets were closed on Tuesday for May Day. The Stoxx Europe 60...

  10. Warner Chilcott Confirms Strategic Review; In Talks With Potential Suitors

    Ireland-based drug maker Warner Chilcott PLC (WCRX) is back at the bargaining table, confirming Monday that it is evaluating options for its business, and is holding...

  11. Bayer CEO: Organic Growth Is Priority, Takeovers Not Ruled Out

    Bayer AG (BAYN.XE) Chief Executive Marijn Dekkers said Thursday organic growth is his priority but didn't rule out acquisitions in the coming years.His statement cam...

  12. Shire Expects Good Earnings Momentum As Profit Rises

    U.K. drug company Shire PLC (SHP.LN) Thursday said it had made a strong start to the year and expects good earnings growth as it posted a rise in first-quarter net i...

  1. FDA Panel Votes Against Expanded Approval Of Bayer , J&J's Xarelto

    A Food and Drug Administration advisory panel narrowly voted against expanded use of Johnson & Johnson's (JNJ) and Bayer AG's (BAYRY, BAYN.XE) anticlotting drug Xare...

  2. Bayer Submits Regorafenib For EU, US. Marketing Authorization

    German pharmaceutical company Bayer AG's (BAYN.XE) HealthCare unit Wednesday said it applied for marketing authorization in the E.U. and the U.S. for its oral drug R...

  3. UK's NICE Gives Final OK for Bayer's Xarelto To Prevent Strokes

    The U.K.'s healthcare cost-effectiveness body Wednesday issued its final recommendation for Bayer AG's (BAYN.XE) anti-clotting pill Xarelto as an option for the prev...

  4. Bayer : Nexavar Lung Cancer Phase III Study Misses Primary Endpoint

    German chemical and pharmaceutical group Bayer AG (BAYN.XE) and Onyx Pharmaceuticals, Inc. (ONXX) Tuesday said a phase III trial of Nexavar treatment for lung cancer...

  5. FDA Reviewer Backs Expanded Approval Of Bayer , J&J's Xarelto

    A Food and Drug Administration medical reviewer recommended the agency expand the approval of Johnson & Johnson's (JNJ) and Bayer AG's (BAYRY, BAYN.XE) anticlotting ...

  6. FDA Reviewer Recommends Expanded Approval Of Bayer , J&J's Xarelto

    A Food and Drug Administration medical reviewer recommended the agency expand the approval of Johnson & Johnson's (JNJ) and Bayer AG's (BAYRY, BAYN.XE) anticlotting ...

  7. Kythera Biopharmaceuticals Files Plans For IPO Of $86.3M In Stock

    Kythera Biopharmaceuticals Inc. filed plans for an estimated initial public offering of up to $86.3 million in common stock.The clinical-stage biopharmaceutical comp...

‹ Prev12345Next ›
Freebase CC-BY
Source: Bayer AG on Freebase, licensed under CC-BY
Other content from Wikipedia, licensed under the GFDL